glp 1 mounjaro (tirzepatide) is a dual incretin agonist targeting both GLP-1 and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying — which also leads to Limited Offer] GIP / GLP-1
Pay in 4 interest-free payments of $5.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
![glp 1 mounjaro (tirzepatide) is a dual incretin agonist targeting both GLP-1 and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to Limited Offer] GIP / GLP-1](https://www.luxora.shop/cdn/shop/files/Gemini_Generated_Image_p756i4p756i4p756.png?v=1775532162&width=480)
![glp 1 mounjaro (tirzepatide) is a dual incretin agonist targeting both GLP-1 and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to Limited Offer] GIP / GLP-1](https://www.manipalhospitals.com/uploads/image_gallery/Ozempic_vs_Mounjaro_A_Doctor%E2%80%99s_Guide_to_Choosing_the_Right_GLP-1_Therapy.png)
![glp 1 mounjaro (tirzepatide) is a dual incretin agonist targeting both GLP-1 and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to Limited Offer] GIP / GLP-1](https://i.guim.co.uk/img/media/0e9dbb52876f6cb9cfbc1cfedafddfe78f6dd6bc/510_0_7655_6124/master/7655.jpg?width=465&dpr=1&s=none&crop=none)
![glp 1 mounjaro (tirzepatide) is a dual incretin agonist targeting both GLP-1 and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying which also leads to Limited Offer] GIP / GLP-1](https://imgctf--assets.ro.co/jj2wf7627pjc/2JLUqXfTVQM5EbxxbvsDxA/2d66e19c29c84e0a5f65c4200801e30e/01_2x.png?fm=webp&q=80&w=1824)
























